|
Post by awesomo on Jun 7, 2023 11:18:50 GMT -5
Well I had never even heard or cared about InvestorPlace until it was being brought up here. Maybe we should just ignore them instead of bringing attention to them by complaining about them.
|
|
|
Post by prcgorman2 on Jun 7, 2023 11:39:16 GMT -5
I wonder if the InvestorPlace hit pieces are part of the issue? Reporting Afrezza quarterly revenue is $12M is misleading. MNKD IR might want to tell MarketWise they need to print a retraction on that particular part of their hit piece. Why is it misleading? Because they didn’t carry the decimal point? Hardly warrants any attention on a nothing article. Decimal point? Are you suggesting it should say $1.2M per quarter for Afrezza? Or did you mean $120M per quarter?
Take a look at Earl Grey's charts most recently posted by Porkini in the Afrezza Script Counts thread which indicate approaching $24M per quarter, or nearly $92M EOY 2023 (and if the trend holds, would be ~$120M in 2024, and that's without V-Go).
|
|
|
Post by awesomo on Jun 7, 2023 11:46:21 GMT -5
Why is it misleading? Because they didn’t carry the decimal point? Hardly warrants any attention on a nothing article. Decimal point? Are you suggesting it should say $1.2M per quarter for Afrezza? Or did you mean $120M per quarter?
Take a look at Earl Grey's charts most recently posted by Porkini in the Afrezza Script Counts thread which indicate approaching $24M per quarter, or nearly $92M EOY 2023 (and if the trend holds, would be ~$120M in 2024, and that's without V-Go).
Or you can go to MannKind's actual earnings page and see that is clearly states Afrezza quarterly revenue at $12.4M. investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2023-first-quarter-financialAlso, once again please stop using Symphony retail sales as revenue to the company. MannKind usually gets about 40-50% of Symphony numbers.
|
|
|
Post by peppy on Jun 7, 2023 11:46:44 GMT -5
MNKD volume at the half day of trade, real time Volume: 1,417,254
$4.1547. -0.1653 (-3.8264%)
|
|
|
Post by prcgorman2 on Jun 7, 2023 11:49:44 GMT -5
Decimal point? Are you suggesting it should say $1.2M per quarter for Afrezza? Or did you mean $120M per quarter?
Take a look at Earl Grey's charts most recently posted by Porkini in the Afrezza Script Counts thread which indicate revenue approaching $24M per quarter, or nearly $92M EOY 2023 (and if the trend holds, would be ~$120M in 2024, and that's without V-Go).
Or you can go to MannKind's actual earnings page and see that is clearly states Afrezza quarterly revenue at $12.4M. investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2023-first-quarter-financialAlso, once again please stop using Symphony retail sales as revenue to the company. MannKind usually gets about 40-50% of Symphony numbers. Once again, let me provide you a link to a definition of revenue. To save you some time (because I'm nice that way), the first sentence of the first paragraph says, "Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations."
|
|
|
Post by awesomo on Jun 7, 2023 11:51:28 GMT -5
Once again, let me provide you a link to a definition of revenue. To save you some time (because I'm nice that way), the first sentence of the first paragraph says, "Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations."
So now you're doubling down and arguing with MannKind's actual financial statements?
|
|
|
Post by porkini on Jun 7, 2023 13:07:30 GMT -5
If you all need a thread to discuss "revenue" I suggest using the "Search" function and find an existing thread with "revenue" in the subject or begin a new thread. This thread is for daily stock volume discussion.
|
|
|
Post by prcgorman2 on Jun 7, 2023 13:46:07 GMT -5
Once again, let me provide you a link to a definition of revenue. To save you some time (because I'm nice that way), the first sentence of the first paragraph says, "Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations."
So now you're doubling down and arguing with MannKind's actual financial statements? Apologies to porkini in advance (for staying off topic), and to you for getting this wrong, again. I must have some mental block about it. I know better. You're absolutely right. MNKD sells to doctors, but actual revenue comes from purchases of Afrezza by pharmacies (or distributors) which is less than what is reported by Symphony (which is less than actual because they don't cover all of the pharmacies), so the total sales revenue using the proper definition is exactly what is reported by MNKD, not Symphony. (Keep repeating, not Symphony, not Symphony.)
|
|
|
Post by peppy on Jun 7, 2023 15:04:39 GMT -5
MNKD volume at the half day of trade, real time Volume: 1,417,254 $4.1547. -0.1653 (-3.8264%) MNKD Nasdaq real time volume, 3,070,965 shares. MNKD Nasdaq summary volume, 3,051,887 Avg. Volume 3,206,577 $4.21 -0.11 (-2.55%) Charts above prior page, these charts refresh
|
|
|
Post by peppy on Jun 8, 2023 11:45:43 GMT -5
MNKD volume at the half day of trade, real time, 1,008,973 summary, 1,010,852 Avg. Volume 3,229,090
$4.12. -0.09 (-2.1378)
Nasdaq 13,222.59 +117.69(+0.90%)
|
|
|
Post by diski58 on Jun 8, 2023 13:13:45 GMT -5
MNKD volume at the half day of trade, real time, 1,008,973 summary, 1,010,852 Avg. Volume 3,229,090 $4.12. -0.09 (-2.1378) Nasdaq 13,222.59 +117.69(+0.90%) As the old saying goes “when one door closes, another one opens” It appears UTHR’s door is opening as it’s about to climb out of its downtrend and fill its open gap on the way up and MNKD’s door is closing as it “appears” to be heading downward to close its open gap at around $ 3.85 ish. Have to play the cards were dealt and have a GTC order in at $3.85 just in case! And, then maybe it will turn around and follow UTHR on the way up? The family dog gave me a dirty look because I took the money from his college fund, but he’ll get over it I hope. Lol
|
|
|
Post by ktim on Jun 8, 2023 14:16:16 GMT -5
If only VIX were a bit higher... getting close to wanting to sell some more Jan $4 puts. Wish MNKD had some June '24 options.
|
|
|
Post by peppy on Jun 8, 2023 15:21:41 GMT -5
MNKD volume at the half day of trade, real time, 1,008,973 summary, 1,010,852 Avg. Volume 3,229,090 $4.12. -0.09 (-2.1378) Nasdaq 13,222.59 +117.69(+0.90%) As the old saying goes “when one door closes, another one opens” It appears UTHR’s door is opening as it’s about to climb out of its downtrend and fill its open gap on the way up and MNKD’s door is closing as it “appears” to be heading downward to close its open gap at around $ 3.85 ish. Have to play the cards were dealt and have a GTC order in at $3.85 just in case! And, then maybe it will turn around and follow UTHR on the way up? The family dog gave me a dirty look because I took the money from his college fund, but he’ll get over it I hope. Lol I think you have nailed it diski58. I was hoping that dime was a break away gap 10 trading days ago. MNKD Nasdaq real time volume, 2,850,747 shares. MNKD Nasdaq summary volume, 2,825,490 Avg. Volume 3,229,090 $4.12. -0.09 (-2.14%) ugg.
|
|
|
Post by runner on Jun 8, 2023 18:14:26 GMT -5
As the old saying goes “when one door closes, another one opens” It appears UTHR’s door is opening as it’s about to climb out of its downtrend and fill its open gap on the way up and MNKD’s door is closing as it “appears” to be heading downward to close its open gap at around $ 3.85 ish. Have to play the cards were dealt and have a GTC order in at $3.85 just in case! And, then maybe it will turn around and follow UTHR on the way up? The family dog gave me a dirty look because I took the money from his college fund, but he’ll get over it I hope. Lol I think you have nailed it diski58. I was hoping that dime was a break away gap 10 trading days ago. MNKD Nasdaq real time volume, 2,850,747 shares. MNKD Nasdaq summary volume, 2,825,490 Avg. Volume 3,229,090 $4.12. -0.09 (-2.14%) ugg. Another version of that old saying is “when one door closes another one slams in your face.” That’s pretty much been my experience of 15 years in mannkind stock
|
|
|
Post by peppy on Jun 8, 2023 18:58:31 GMT -5
We can see on continuous glucose monitors, dosing afrezza correctly gives the type 1 diabetic control of their food choices and blood glucose levels.
(No matter what aged says)
We are not blind we can see.
Big business doesn't care.
I see.
|
|